Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.5069
+0.0132 (2.67%)
Sep 10, 2026, 11:29 AM EDT - Market open
Impact BioMedical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.01 | 0 | 2 | 0 | 0 | 0.05 |
Cash & Short-Term Investments | 0.01 | 0 | 2 | 0 | 0 | 0.05 |
Cash Growth | -98.40% | -99.85% | 199800.00% | -50.00% | -95.65% | -36.42% |
Accounts Receivable | - | 0.01 | - | - | - | - |
Other Receivables | - | - | - | 0.13 | - | - |
Receivables | 0.2 | 0.2 | 0.18 | 0.33 | 0.02 | 0.2 |
Inventory | 0.06 | 0.06 | - | - | - | - |
Prepaid Expenses | 0.05 | 0.14 | 0.26 | - | 0.06 | 0 |
Other Current Assets | - | 0 | 0 | - | 0.04 | 0.04 |
Total Current Assets | 0.32 | 0.41 | 2.45 | 0.33 | 0.12 | 0.29 |
Property, Plant & Equipment | - | - | 0.02 | 0.29 | 0.28 | - |
Long-Term Investments | - | - | - | - | 0.78 | 4.82 |
Goodwill | - | - | - | 25.09 | 25.09 | 25.09 |
Other Intangible Assets | 16.43 | 16.99 | 17.81 | 18.92 | 20.03 | 21.15 |
Total Assets | 16.75 | 17.41 | 20.29 | 44.63 | 46.5 | 56.43 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.47 | 0.35 | 0.31 | 0.83 | 0.54 | 0.12 |
Accrued Expenses | 0.25 | 0.19 | 0.19 | 0.23 | 0.06 | 0.01 |
Short-Term Debt | - | - | 8.88 | 12.07 | 9.99 | 12.52 |
Other Current Liabilities | 1.33 | 0.62 | 0.4 | - | - | - |
Total Current Liabilities | 2.05 | 1.16 | 9.79 | 13.14 | 10.59 | 12.65 |
Long-Term Deferred Tax Liabilities | 0.69 | 0.69 | 3.27 | 3.24 | 3.24 | 3.86 |
Total Liabilities | 2.73 | 1.85 | 13.05 | 16.37 | 13.83 | 16.5 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.11 | 0.11 | 0.01 | 0.01 | 0.07 | 0.13 |
Additional Paid-In Capital | 63.15 | 62.01 | 41.86 | 38.11 | 38.11 | 38.06 |
Retained Earnings | -52.49 | -49.51 | -37.67 | -12.96 | -8.63 | -1.57 |
Total Common Equity | 10.77 | 12.61 | 4.2 | 25.16 | 29.56 | 36.61 |
Minority Interest | 3.25 | 2.95 | 2.98 | 3.04 | 3.11 | 3.32 |
Shareholders' Equity | 14.01 | 15.56 | 7.24 | 28.26 | 32.67 | 39.92 |
Total Liabilities & Equity | 16.75 | 17.41 | 20.29 | 44.63 | 46.5 | 56.43 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | - | 8.88 | 12.07 | 9.99 | 12.52 |
Net Cash (Debt) | 0.01 | 0 | -6.88 | -12.07 | -9.99 | -12.48 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | 0.00 | 0.00 | -0.64 | -0.20 | -0.14 | -0.18 |
Filing Date Shares Outstanding | 107.82 | 107.82 | 12.09 | 10 | 70.5 | 70.5 |
Total Common Shares Outstanding | 107.82 | 104.62 | 11.5 | 10 | 70.5 | 70.5 |
Working Capital | -1.73 | -0.75 | -7.34 | -12.8 | -10.47 | -12.36 |
Book Value Per Share | 0.10 | 0.12 | 0.37 | 2.52 | 0.42 | 0.52 |
Tangible Book Value | -5.66 | -4.39 | -13.61 | -18.85 | -15.57 | -9.63 |
Tangible Book Value Per Share | -0.05 | -0.04 | -1.18 | -1.89 | -0.22 | -0.14 |
Machinery | - | - | 0.03 | - | 0.03 | - |
Construction In Progress | - | - | - | - | 0.25 | - |